Nexalin Technology (NXL)

• Market cap: $53.6M
• 1 day: 1.46%
• 5 days: 6.11%
• 1 month: 53.87%
• 3 months: 363.33%
• 6 months: 479.17%
• Year to date: 946.95%
• 1 year: 853.58%
• 5 years: 85.33%
• 10 years: 85.33%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

15% more funds holding

Funds holding: 13 [Q2] → 15 (+2) [Q3]

0.38% less ownership

Funds ownership: 4.43% [Q2] → 4.05% (-0.38%) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

52% less capital invested

Capital invested by funds: $568K [Q2] → $271K (-$297K) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $3 28% downside
• Avg. target: $3 28% downside
• High target: $3 28% downside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Anthony Vendetti 64% 1-year accuracy 7 / 11 met price target

28% downside $3

Buy Initiated

9 Oct 2024